论文部分内容阅读
Nanocarriers have shown great potential for targeting delivery of therapeutic molecules to tumors[1].Compared to small molecule anti-cancer drugs,nanomedicines with the features of tumor targeting,long blood circulating time,high drug accumulation in tumor tissues,and low toxicity to normal tissues are a more promising therapeutics in cancer treatment[2].